Viewing Study NCT02278120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-02-19 @ 3:43 PM
Study NCT ID: NCT02278120
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2014-10-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LEE011 View
None ribociclib View
None HR-positive View
None HER2-negative View
None Advanced breast cancer View
None Letrozole View
None Anastrozole View
None Tamoxifen View
None Goserelin View
None CDK View
None CDK4 View
None CDK6 View
None CDK4/6 View
None Phase III View
None ER-positive View
None PR-positive View
None Premenopausal View